Insider Trading › AORT › Insiders
ARTIVION, INC.
AORT·NYSE·
United States·Insider activity
United States·Insider activity$21.84
-0.77 (-3.41%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
AORT
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AORTS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, AORT insiders filed 0 purchases ($0) and 9 sales ($3.5M) on the open market, by 4 insiders. Newest filing Sep 11, 2026 (26 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by AORT insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$3.5MSales · 180 days
265Open-market transactions on record
4Insiders filing · 180 days
Purchases (code P) and sales (code S) of AORT common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
265 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| GREEN ANDREW MSVP, Regulatory and Quality | Sale | −11.5K | $24.97 | $287K | 40.2Kdirect | Sep 10, 2026 | Sep 11, 2026 | Form 4 ↗ |
| GREEN ANDREW MSVP, Regulatory and Quality | Sale | −1,493 | $26.02 | $39K | 51.6Kdirect | Sep 3, 2026 | Sep 4, 2026 | Form 4 ↗ |
| GREEN ANDREW MSVP, Regulatory and Quality | Sale | −6,510 | $27.27 | $177K | 53.1Kdirect | Sep 2, 2026 | Sep 4, 2026 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −70.0K | $28.95 | $2.0M | 877.3Kdirect | Aug 19, 2026 | Aug 20, 2026 | Form 4 ↗ |
| GREEN ANDREW MSVP, Regulatory and Quality | Sale | −616 | $28.55 | $18K | 59.6Kdirect | Aug 14, 2026 | Aug 17, 2026 | Form 4 ↗ |
| Berry Lance AEVP, COO, CFO & Treasurer | Sale | −715 | $28.55 | $20K | 210.1Kdirect | Aug 14, 2026 | Aug 17, 2026 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −977 | $28.49 | $28K | 184.1Kdirect | Aug 12, 2026 | Aug 12, 2026 | Form 4 ↗ |
| GREEN ANDREW MSVP, Regulatory and Quality | Sale | −30.0K | $20.69 | $621K | 60.3Kdirect | Jun 11, 2026 | Jun 15, 2026 | Form 4 ↗ |
| GREEN ANDREW MSVP, Regulatory and Quality | Sale | −14.0K | $20.71 | $290K | 60.3Kdirect | Jun 11, 2026 | Jun 15, 2026 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −8,962 | $38.00 | $341K | 185.1Kdirect | Mar 4, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −901 | $37.78 | $34K | 139.1Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −3,843 | $37.78 | $145K | 194.1Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −2,149 | $37.78 | $81K | 60.1Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −4,573 | $37.78 | $173K | 230.8Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Berry Lance AEVP, COO, CFO & Treasurer | Sale | −6,316 | $37.78 | $239K | 210.8Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −17.9K | $37.78 | $676K | 947.3Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −641 | $38.02 | $24K | 132.5Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,513 | $38.02 | $58K | 40.4Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −14.9K | $38.02 | $567K | 848.2Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −2,183 | $38.02 | $83K | 170.1Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Berry Lance AEVP, COO, CFO & Treasurer | Sale | −5,178 | $38.02 | $197K | 176.3Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −2,784 | $38.02 | $106K | 206.5Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −830 | $35.69 | $30K | 127.5Kdirect | Feb 24, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,259 | $35.69 | $45K | 41.9Kdirect | Feb 24, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −1,668 | $35.69 | $60K | 152.2Kdirect | Feb 24, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −13.9K | $35.69 | $497K | 766.1Kdirect | Feb 24, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Berry Lance AEVP, COO, CFO & Treasurer | Sale | −4,485 | $35.69 | $160K | 144.0Kdirect | Feb 24, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −2,075 | $35.69 | $74K | 188.9Kdirect | Feb 24, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −1,731 | $37.59 | $65K | 128.3Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −2,423 | $37.59 | $91K | 43.2Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −3,079 | $37.59 | $116K | 153.9Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −21.0K | $37.59 | $788K | 780.0Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Berry Lance AEVP, COO, CFO & Treasurer | Sale | −4,981 | $37.59 | $187K | 148.4Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −3,773 | $37.59 | $142K | 190.9Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −5,000 | $45.11 | $226K | 193.8Kdirect | Dec 15, 2025 | Dec 17, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −4,572 | $44.42 | $203K | 130.1Kdirect | Dec 8, 2025 | Dec 9, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −30.9K | $45.46 | $1.4M | 801.0Kdirect | Dec 3, 2025 | Dec 4, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −5,267 | $45.30 | $239K | 156.1Kdirect | Dec 3, 2025 | Dec 4, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −2,048 | $45.30 | $93K | 161.4Kdirect | Dec 3, 2025 | Dec 4, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −30.9K | $45.56 | $1.4M | 801.0Kdirect | Dec 2, 2025 | Dec 3, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −8,370 | $45.35 | $380K | 44.8Kdirect | Nov 21, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −18.7K | $44.91 | $840K | 53.1Kdirect | Nov 21, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −5,715 | $45.35 | $259K | 44.8Kdirect | Nov 21, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −14.6K | $44.92 | $655K | 50.5Kdirect | Nov 21, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,355 | $44.28 | $60K | 44.8Kdirect | Nov 20, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −2,033 | $44.32 | $90K | 44.8Kdirect | Nov 20, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −11.9K | $44.14 | $525K | 44.8Kdirect | Nov 20, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Hoff Elizabeth ADirector | Sale | −4,200 | $45.10 | $189K | 27.2Kdirect | Nov 18, 2025 | Nov 19, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −6,394 | $45.17 | $289K | 163.4Kdirect | Nov 17, 2025 | Nov 18, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −6,394 | $45.17 | $289K | 198.8Kdirect | Nov 17, 2025 | Nov 18, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −6,000 | $45.73 | $274K | 135.4Kdirect | Nov 17, 2025 | Nov 18, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −6,393 | $45.00 | $288K | 163.4Kdirect | Nov 14, 2025 | Nov 18, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −6,393 | $44.67 | $286K | 198.8Kdirect | Nov 14, 2025 | Nov 18, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −3,482 | $45.86 | $160K | 141.4Kdirect | Nov 13, 2025 | Nov 14, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −6,563 | $45.86 | $301K | 198.8Kdirect | Nov 13, 2025 | Nov 14, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −34.2K | $45.86 | $1.6M | 801.0Kdirect | Nov 13, 2025 | Nov 14, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −5,761 | $45.86 | $264K | 163.4Kdirect | Nov 13, 2025 | Nov 14, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −4,993 | $45.86 | $229K | 56.6Kdirect | Nov 13, 2025 | Nov 14, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −10.0K | $46.18 | $462K | 169.2Kdirect | Nov 11, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −2,960 | $44.62 | $132K | 169.2Kdirect | Nov 10, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −17.6K | $44.62 | $784K | 835.2Kdirect | Nov 10, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −3,373 | $44.62 | $151K | 205.4Kdirect | Nov 10, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −1,789 | $44.62 | $80K | 144.9Kdirect | Nov 10, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −2,566 | $44.62 | $114K | 61.6Kdirect | Nov 10, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −18.2K | $44.02 | $801K | 64.2Kdirect | Aug 27, 2025 | Aug 28, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −10.0K | $44.37 | $444K | 172.1Kdirect | Aug 25, 2025 | Aug 26, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −12.5K | $42.32 | $529K | 852.8Kdirect | Aug 15, 2025 | Aug 19, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −10.8K | $43.67 | $472K | 208.8Kdirect | Aug 12, 2025 | Aug 14, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −6,381 | $43.02 | $275K | 172.1Kdirect | Aug 12, 2025 | Aug 14, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −17.0K | $43.01 | $730K | 178.5Kdirect | Aug 12, 2025 | Aug 14, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −7,992 | $38.49 | $308K | 146.7Kdirect | Aug 8, 2025 | Aug 11, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,236 | $29.50 | $36K | 64.2Kdirect | Jun 17, 2025 | Jun 18, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −13.8K | $29.50 | $406K | 65.4Kdirect | Jun 17, 2025 | Jun 18, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,826 | $28.43 | $52K | 79.2Kdirect | Jun 13, 2025 | Jun 16, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −14.3K | $28.42 | $407K | 81.0Kdirect | Jun 13, 2025 | Jun 16, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,253 | $28.47 | $36K | 95.3Kdirect | Jun 13, 2025 | Jun 16, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −8,747 | $28.46 | $249K | 96.6Kdirect | Jun 13, 2025 | Jun 16, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −8,748 | $29.00 | $254K | 178.5Kdirect | May 27, 2025 | May 27, 2025 | Form 4 ↗ |
| SEMEDO ANTHONY B.Director | Sale Amended | −2,600 | $28.47 | $74K | 39.4Kdirect | May 23, 2025 | May 27, 2025 | Form 4 ↗ |
| SEMEDO ANTHONY B.Director | Sale | −2,600 | $28.47 | $74K | 33.1Kdirect | May 23, 2025 | May 27, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −9,926 | $29.00 | $288K | 187.3Kdirect | May 21, 2025 | May 21, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −4,811 | $29.13 | $140K | 105.3Kdirect | May 9, 2025 | May 12, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −5,737 | $29.13 | $167K | 110.1Kdirect | May 9, 2025 | May 12, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −18.0K | $23.61 | $425K | 197.2Kdirect | Mar 11, 2025 | Mar 12, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −15.1K | $23.61 | $357K | 208.8Kdirect | Mar 11, 2025 | Mar 12, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −70.7K | $24.76 | $1.8M | 865.3Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −17.7K | $24.80 | $440K | 860.4Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −1,048 | $24.80 | $26K | 146.7Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Berry Lance AExecutive VP, CFO | Sale | −4,909 | $24.80 | $122K | 153.4Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −2,618 | $24.80 | $65K | 208.0Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,603 | $24.80 | $40K | 115.9Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −2,124 | $24.80 | $53K | 196.1Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −472 | $25.29 | $12K | 172.7Kdirect | Mar 5, 2025 | Mar 6, 2025 | Form 4 ↗ |
| SEMEDO ANTHONY B.Director | Purchase | +600 | $25.25 | $15K | 600indirect | Mar 5, 2025 | Mar 5, 2025 | Form 4 ↗ |
| SEMEDO ANTHONY B.Director | Purchase | +1,500 | $25.33 | $38K | 35.7Kdirect | Mar 5, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −485 | $27.31 | $13K | 131.1Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −318 | $27.31 | $9K | 131.6Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −814 | $27.31 | $22K | 131.9Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −1,706 | $27.31 | $47K | 132.8Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −4,896 | $27.31 | $134K | 663.9Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −6,812 | $27.31 | $186K | 668.8Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −13.8K | $27.31 | $376K | 675.6Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −16.7K | $27.31 | $455K | 689.4Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −1,650 | $27.31 | $45K | 149.8Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −810 | $27.31 | $22K | 151.4Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −490 | $27.31 | $13K | 152.3Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −2,385 | $27.31 | $65K | 152.7Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −2,035 | $27.31 | $56K | 160.6Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −985 | $27.31 | $27K | 162.7Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −591 | $27.31 | $16K | 163.7Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −2,846 | $27.31 | $78K | 164.2Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Berry Lance AExecutive VP, CFO | Sale | −3,259 | $27.31 | $89K | 75.8Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,246 | $27.31 | $34K | 79.8Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −672 | $27.31 | $18K | 81.1Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −470 | $27.31 | $13K | 81.8Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −2,299 | $27.31 | $63K | 82.2Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −4,035 | $30.00 | $121K | 153.9Kdirect | Dec 11, 2024 | Dec 12, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −4,035 | $30.25 | $122K | 157.9Kdirect | Dec 11, 2024 | Dec 12, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale Amended | −4,425 | $29.05 | $129K | 135.6Kdirect | Dec 6, 2024 | Dec 10, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −4,329 | $29.66 | $128K | 135.7Kdirect | Dec 6, 2024 | Dec 9, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −7,618 | $30.00 | $229K | 33.5Kdirect | Dec 4, 2024 | Dec 4, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −12.4K | $26.18 | $325K | 140.0Kdirect | Oct 1, 2024 | Oct 2, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −3,167 | $26.55 | $84K | 161.9Kdirect | Aug 26, 2024 | Aug 27, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −2,562 | $25.31 | $65K | 34.1Kdirect | Aug 16, 2024 | Aug 19, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −6,858 | $25.31 | $174K | 36.7Kdirect | Aug 16, 2024 | Aug 19, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −2,383 | $25.76 | $61K | 165.1Kdirect | Aug 15, 2024 | Aug 16, 2024 | Form 4 ↗ |
| SEMEDO ANTHONY B.Director | Sale | −9,709 | $24.99 | $243K | 34.2Kdirect | Aug 13, 2024 | Aug 15, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −1,250 | $23.42 | $29K | 167.5Kdirect | May 10, 2024 | May 13, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −979 | $23.79 | $23K | 168.7Kdirect | May 9, 2024 | May 10, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −2,183 | $20.39 | $45K | 83.3Kdirect | Mar 20, 2024 | Mar 21, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −1,462 | $20.00 | $29K | 41.1Kdirect | Mar 15, 2024 | Mar 18, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −3,994 | $20.00 | $80K | 42.6Kdirect | Mar 14, 2024 | Mar 15, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −5,000 | $19.94 | $100K | 43.5Kdirect | Mar 12, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale Amended | −1,152 | $18.72 | $22K | 140.0Kdirect | Mar 5, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale Amended | −1,157 | $18.72 | $22K | 46.6Kdirect | Mar 5, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale Amended | −2,380 | $18.72 | $45K | 169.7Kdirect | Mar 5, 2024 | Mar 14, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale Amended | −1,160 | $18.72 | $22K | 46.6Kdirect | Mar 5, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale Amended | −1,157 | $18.72 | $22K | 48.5Kdirect | Mar 5, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale Amended | −2,022 | $18.72 | $38K | 165.7Kdirect | Mar 5, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale Amended | −14.0K | $18.72 | $262K | 706.0Kdirect | Mar 5, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −14.0K | $18.72 | $262K | 705.6Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −2,380 | $18.72 | $45K | 169.7Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −2,022 | $18.72 | $38K | 165.6Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −1,157 | $18.72 | $22K | 48.5Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −1,157 | $18.72 | $22K | 46.5Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −1,160 | $18.72 | $22K | 46.5Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,506 | $18.72 | $28K | 85.4Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −1,152 | $18.72 | $22K | 140.0Kdirect | Mar 5, 2024 | Mar 7, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale Amended | −1,506 | $18.72 | $28K | 85.5Kdirect | Mar 1, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale Amended | −465 | $19.83 | $9K | 81.3Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale Amended | −370 | $19.83 | $7K | 44.1Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale Amended | −421 | $19.83 | $8K | 44.2Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale Amended | −325 | $19.83 | $6K | 137.6Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale Amended | −584 | $19.83 | $12K | 162.0Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale Amended | −485 | $19.83 | $10K | 166.4Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale Amended | −325 | $19.83 | $6K | 46.1Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale Amended | −4,837 | $19.83 | $96K | 691.4Kdirect | Feb 27, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Tyrs FlorianVP, Global Operations | Sale | −339 | $19.83 | $7K | 21.6Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −325 | $19.83 | $6K | 137.5Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −4,837 | $19.83 | $96K | 690.9Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −485 | $19.83 | $10K | 166.3Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −584 | $19.83 | $12K | 161.9Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −370 | $19.83 | $7K | 44.1Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −325 | $19.83 | $6K | 46.1Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −421 | $19.83 | $8K | 44.1Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −465 | $19.83 | $9K | 81.2Kdirect | Feb 27, 2024 | Feb 29, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale Amended | −966 | $20.27 | $20K | 137.9Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale Amended | −1,168 | $20.27 | $24K | 132.4Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale Amended | −1,431 | $20.27 | $29K | 81.7Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale Amended | −1,576 | $20.27 | $32K | 72.5Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale Amended | −1,114 | $20.27 | $23K | 44.5Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale Amended | −1,168 | $20.27 | $24K | 39.2Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale Amended | −1,543 | $20.27 | $31K | 166.9Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale Amended | −1,295 | $20.27 | $26K | 155.6Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale Amended | −1,199 | $20.27 | $24K | 44.6Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale Amended | −1,168 | $20.27 | $24K | 38.9Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale Amended | −1,875 | $20.27 | $38K | 162.6Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale Amended | −1,586 | $20.27 | $32K | 151.7Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale Amended | −13.0K | $20.27 | $263K | 696.3Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale Amended | −17.9K | $20.27 | $362K | 650.6Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale Amended | −1,112 | $20.27 | $23K | 46.4Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale Amended | −1,168 | $20.27 | $24K | 40.1Kdirect | Feb 26, 2024 | Mar 14, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −980 | $20.27 | $20K | 137.9Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −1,186 | $20.27 | $24K | 132.4Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −13.2K | $20.27 | $267K | 695.8Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −18.1K | $20.27 | $368K | 650.3Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −1,566 | $20.27 | $32K | 166.8Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −1,314 | $20.27 | $27K | 155.5Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −1,130 | $20.27 | $23K | 44.5Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −1,185 | $20.27 | $24K | 39.2Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −1,904 | $20.27 | $39K | 162.5Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −1,610 | $20.27 | $33K | 151.7Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −1,128 | $20.27 | $23K | 46.4Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −1,185 | $20.27 | $24K | 40.1Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −1,218 | $20.27 | $25K | 44.5Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −1,185 | $20.27 | $24K | 38.8Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,448 | $20.27 | $29K | 81.7Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,600 | $20.27 | $32K | 72.5Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Tyrs FlorianVP, Global Operations | Sale | −893 | $20.27 | $18K | 21.9Kdirect | Feb 26, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −1,192 | $18.87 | $22K | 131.9Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −464 | $18.87 | $9K | 133.1Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −1,871 | $18.87 | $35K | 133.5Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −366 | $18.87 | $7K | 122.3Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −1,329 | $18.87 | $25K | 122.7Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −496 | $18.87 | $9K | 128.2Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Davis John EChief Commercial Officer | Sale | −2,060 | $18.87 | $39K | 128.7Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −407 | $18.87 | $8K | 29.1Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −366 | $18.87 | $7K | 28.7Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −1,329 | $18.87 | $25K | 29.1Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Tyrs FlorianVP, Global Operations | Sale | −249 | $18.87 | $5K | 16.3Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −2,756 | $18.87 | $52K | 539.0Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −10.1K | $18.87 | $190K | 541.8Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −59.2K | $18.85 | $1.1M | 551.9Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −21.2K | $18.00 | $382K | 133.5Kdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Davis John ESenior VP, Global Sales | Sale | −13.6K | $18.00 | $244K | 128.7Kdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −14.4K | $19.00 | $274K | 124.0Kdirect | Dec 15, 2023 | Dec 19, 2023 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −2,101 | $17.34 | $36K | 105.6Kdirect | Nov 27, 2023 | Nov 29, 2023 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −6,329 | $15.88 | $101K | 30.4Kdirect | Jun 7, 2023 | Jun 8, 2023 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −378 | $15.34 | $6K | 34.7Kdirect | Jun 6, 2023 | Jun 8, 2023 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −15.9K | $15.27 | $242K | 35.1Kdirect | Jun 6, 2023 | Jun 8, 2023 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −1,121 | $13.41 | $15K | 51.0Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −821 | $13.41 | $11K | 29.5Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −702 | $13.41 | $9K | 107.7Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −702 | $13.41 | $9K | 36.7Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −9,990 | $13.41 | $134K | 551.9Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −825 | $13.41 | $11K | 25.6Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| LEE DAVID ASHLEYExecutive VP, COO & CFO | Sale | −1,401 | $13.41 | $19K | 347.2Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −907 | $13.41 | $12K | 52.1Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Davis John ESenior VP, Global Sales | Sale | −1,121 | $13.41 | $15K | 128.7Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −907 | $13.41 | $12K | 133.5Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −406 | $13.24 | $5K | 28.1Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −672 | $12.94 | $9K | 106.1Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −747 | $12.94 | $10K | 102.5Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| LEE DAVID ASHLEYExecutive VP, COO & CFO | Sale | −1,602 | $12.94 | $21K | 344.0Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| LEE DAVID ASHLEYExecutive VP, COO & CFO | Sale | −1,492 | $12.94 | $19K | 335.5Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −994 | $12.94 | $13K | 130.8Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Holloway Jean FSVP, General Counsel | Sale | −966 | $12.94 | $13K | 124.0Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Davis John ESenior VP, Global Sales | Sale | −1,208 | $12.94 | $16K | 126.2Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Davis John ESenior VP, Global Sales | Sale | −1,185 | $12.94 | $15K | 119.8Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −878 | $12.94 | $11K | 25.0Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −869 | $12.94 | $11K | 24.1Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| GREEN ANDREW MVP Regulatory | Sale | −878 | $12.94 | $11K | 20.3Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −9,985 | $12.94 | $129K | 540.1Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −12.6K | $12.94 | $164K | 507.9Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −982 | $12.94 | $13K | 48.4Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −1,348 | $12.94 | $17K | 43.1Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,161 | $12.94 | $15K | 49.3Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Stanton Marshall S.SVP, Clinical & MD Affair | Sale | −1,176 | $12.94 | $15K | 43.0Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −722 | $12.94 | $9K | 35.1Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Getz Matthew AVP, Human Resources | Sale | −878 | $12.94 | $11K | 31.6Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −3,000 | $14.13 | $42K | 102.7Kdirect | Feb 17, 2023 | Feb 21, 2023 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −15.0K | $14.08 | $211K | 102.7Kdirect | Feb 17, 2023 | Feb 21, 2023 | Form 4 ↗ |
| LEE DAVID ASHLEYExecutive VP, COO & CFO | Sale | −31.9K | $13.22 | $422K | 335.6Kdirect | Feb 14, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −56.5K | $13.22 | $747K | 505.7Kdirect | Feb 14, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Horton AmyVP, Chief Accounting Officer | Sale | −3,226 | $13.57 | $44K | 102.0Kdirect | Dec 14, 2022 | Dec 16, 2022 | Form 4 ↗ |
| Maney Rochelle L.VP, Quality | Sale | −7,161 | $22.96 | $164K | 12.3Kdirect | Aug 16, 2022 | Aug 18, 2022 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −1,025 | $21.61 | $22K | 22.8Kdirect | Aug 9, 2022 | Aug 10, 2022 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −374 | $21.61 | $8K | 23.8Kdirect | Aug 9, 2022 | Aug 10, 2022 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −540 | $21.61 | $12K | 24.2Kdirect | Aug 9, 2022 | Aug 10, 2022 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −3,678 | $21.61 | $79K | 24.7Kdirect | Aug 9, 2022 | Aug 10, 2022 | Form 4 ↗ |
| Maier Dennis BSVP, Operations | Sale | −145 | $21.67 | $3K | 28.4Kdirect | Aug 9, 2022 | Aug 10, 2022 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −10.6K | $17.86 | $190K | 304.2Kdirect | Feb 10, 2022 | Feb 11, 2022 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −10.6K | $18.14 | $193K | 304.2Kdirect | Feb 9, 2022 | Feb 11, 2022 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −10.6K | $17.75 | $189K | 304.2Kdirect | Feb 8, 2022 | Feb 10, 2022 | Form 4 ↗ |
| Mackin James PPresident & CEO | Sale | −10.6K | $17.30 | $184K | 304.2Kdirect | Feb 7, 2022 | Feb 8, 2022 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →